| http://www.w3.org/ns/prov#value | - Pharmacodynamics, Safety, and Tolerability of Apixaban in Pediatric Subjects at Risk for a Venous or Arterial Thrombotic Disorder (IRB# 41107) Status: Active Investigators: Principal Investigator: Andrew S. Freiberg, MD Description: In children, ninety-six percent of Venous thromboembolism or VTEs occur in association with serious underlying illness such as cancer and congenital heart disease or
|
